Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Pihlajalinna Oyj: Acquisition of own shares on June 17, 2024

Pihlajalinna Oyj: Acquisition of own shares on June 17, 2024 Pihlajalinna Oyj’s stock exchange release on June 17, 2024, at 07:00 p.m. EET Date June 17, 2024Exchange transaction BuyShare trading code PIHLISAmount, shares 774Average price/share (EUR) 9.5252Total cost (EUR) 7,372.50 After the acquisitions Pihlajalinna Oyj holds a total of 136,055 treasury shares. ON BEHALF OF PIHLAJALINNA OYJ Danske Bank A/S, Finland Branch  Antti Väliaho                        Jonathan Nyberg Additional Information

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 17.06.2024

United Bankers Plc NOTIFICATION   17.06.2024 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 17.06.2024   Date 17.06.2024  Exchange transaction Buy  Share class UNITED  Amount 220  Average price/share 19.1500 EURHighest price/share 19.1500 EURLowest price/share 19.1500 EURTotal price 4,213.00   EUR        The shares held by United Bankers Plc on 17.06.2024   UNITED 9,204         On behalf of United

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)

The following resolutions were passed at Calliditas Therapeutics AB (publ) (“Calliditas”) annual general meeting held today, on 17 June 2024, in Stockholm.Adoption of income statement and balance sheet for the financial year 2023 and discharge from liability The annual general meeting resolved to adopt the income statement and the consolidated income statement for the financial year 2023 as well as the balance sheet and consolidated balance sheet as of 31 December 2023. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2023.

#24-219 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-218 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Exel Composites Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act

EXEL COMPOSITES PLC          STOCK EXCHANGE RELEASE        17 JUNE 2024 AT 18:00 EESTExel Composites Plc has on 17 June 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding of funds managed by OP Fund Management Company Ltd has increased above 5% of the voting rights and share capital in Exel Composites Plc. Through share transactions concluded on 17 June 2024, the holding of funds managed by OP Fund Management Company Ltd amounts to 5,765,946 shares representing 5.40% of the shares and voting rights of Exel

Acroud receives approval from the bondholders in the written procedure for its outstanding bond loan

On 28 May 2024, Acroud AB (publ) (the “Company” or “Acroud”) initiated a written procedure (the “Written Procedure”) under its outstanding bond loan 2022/2025 with ISIN SE0017562481 (the “Bonds”). The Written Procedure was initiated for the purpose of requesting the bondholders’ content for a waiver as summarised in the Company’s press release dated 28 May 2024 and as further set out in the notice of Written Procedure which is available on the websites of the Company and Nordic Trustee & Agency AB (publ) (the “Agent”). All capitalised terms used herein and not otherwise defined shall have the

Hemsö announces the results of the tender offer for certain of its outstanding notes

Hemsö Fastighets AB (“Hemsö”) announces the final results of its invitation to holders of its outstanding EUR 300m notes due 2029 with ISIN XS1632767718 which was announced on 7 June 2024. At the time of the expiration of the tender offer at 17.00 (CEST) on 14 June 2024, Hemsö had received valid tenders of EUR 19,648,000. Hemsö has decided to accept to purchase tendered notes in and an aggregate nominal amount of EUR 19,648,000 at a purchase price of 91.177%. The settlement date of the tender offer is expected to be 19 June 2024. Notes purchased by Hemsö pursuant to the tender offer will

Buy-back of shares in Hemnet during 10 - 14 June, 2024

Hemnet Group AB (publ) (LEI code: 5493008VIU67J3HUAR07) ("Hemnet") has during 10 to 14 June 2024 repurchased in total 26,000 own ordinary shares (ISIN code: SE0015671995) as part of the share buy-back program initiated by the board of directors of Hemnet in order to adjust Hemnet's capital structure.The share buy-backs form part of the share buy-back program of maximum SEK 450,000,000 announced by Hemnet on 25 April 2024. The share buy-back program is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU)

NextCell’s rights issue oversubscribed

THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, CANADA, HONG KONG, BELARUS, RUSSIA OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLISHING OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW. SEE SECTION ”IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. NextCell Pharma AB (publ) (”NextCell” or the “Company”) hereby announces the

Notice of Extraordinary General Meeting

The Board of Directors is pleased to invite shareholders of Curasight A/S (“Curasight” or the “Company”) to an Extraordinary General Meeting on Tuesday 2 July 2024 at 10:00 AM (CET) at the office of DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen OE, Denmark.Agenda 1. Proposals from the Board of Directors 1. 1.1 Authorisation to the Board of Directors to issue warrants with pre-emption rights 2. 1.2 Authorisation to the Board of Directors to issue warrants without pre-emption rights 3. 1.3 Authorisation to the chairman of the meeting Complete proposals 1. Proposals

Lehto Group Plc, inside information: Proposal for Lehto’s restructuring programme has been filed with the District Court of Oulu

Lehto Group PlcInside information17 June 2024 at 16.45 (Finnish time)The administrator of Lehto Group Plc’s (the ”company” or ”Lehto”) corporate restructuring proceedings, attorney Klaus Majamäki, has on 17 June 2024 filed proposal for the company’s restructuring programme with the District Court of Oulu. In the view of the company and the administrator, the restructuring programme would lead to a better outcome for the company's creditors than bankruptcy. The aim of the restructuring programme is, inter alia, to enable the company to start the Energy Construction Business (defined

CS MEDICA Group Completes Product Registration of CANNASEN® CBD-Infused Medical Devices in Israel

Strategic Milestone Achieved as CANNORDIC, a CS MEDICA Subsidiary, Navigates Regulatory ChallengesCS MEDICA Group, a forerunner in innovative substance-based medical devices containing bioactive CBD, announces the successful completion of the product registration process for the entire CANNASEN® portfolio of CBD-infused medical devices in Israel. This achievement marks a regulatory milestone for our subsidiary, CANNORDIC, and sets a new standard for over-the-counter CBD products in the region. The first product, the CANNASEN® Pain Patch, received approval from Israel's Ministry of Health

Ixia Launches $20 Million Global Gaming Venture Fund and Studio

Ixia Capital, a venture capital fund and studio, has launched with an investment of $20 million focused on high-growth companies across gaming, esports, digital assets, and complementary technologies.The fund has been founded by partners with deep firsthand iGaming industry experience, enabling entrepreneurs to realise innovative ideas, technologies, and transform business models into profitable companies. Ixia Capital is a global fund with a focus in India, Africa and UAE where the mission is to accelerate development and manage risks to help ventures succeed in specialised fields. The

ICA Real Estate completes land exchange with the City of Stockholm

On 12 June, ICA Real Estate completed a land exchange with the City of Stockholm where ICA Real Estate divests land for SEK 843 million and at the same time acquires land for SEK 371 million with a net cash flow effect of SEK 472 million.In 2013, ICA Real Estate signed a land allocation agreement and letter of intent on a reparceling with the City of Stockholm involving the divestment and acquisition of land in Årsta. The letter of intent means that ICA Real Estate acquires an additional parcel of land adjacent to Postgården 1 and divests land within Postgården 1 to the City of Stockholm.

Terrafame published its Sustainability Review

Published today, Terrafame’s Sustainability Review describes the main points of the battery chemicals company’s sustainability work and the progress of the sustainability programme in 2023.Sustainability is at the heart of Terrafame’s operations, and the company believes that systematic sustainability development creates a competitive advantage in the global battery chemicals market. The carbon footprint of the nickel sulphate produced by the company is already the smallest in the industry. Additionally, the company’s unique operating model ensures a fully traceable production process, as

ArcticZymes Technologies executes contract with consortium for Advanced therapies enzyme project funded by The Research Council of Norway

Tromsø, Norway, June 17, 2024 - ArcticZymes Technologies ASA (OSE: AZT) has today executed a contract with The Research Council of Norway, securing up to 11.8 MNOK for a collaborative project aimed at supporting the advanced therapy biomanufacturing sector.This follows a previously announced research grant awarded by the Norwegian Research Council. The agreements with the Norwegian Research Council and the project partners, the University of Tromsø - The Arctic University of Norway, and SINTEF Industri have now been finalized, marking the project's commencement. The project has been named

Carbiotix provides update of staff re-organisation

Carbiotix AB (publ) ("Carbiotix" or the "Company") has today provided an update of the staff re-organisation originally communicated on May 28th. Five individuals will be impacted by the re-organisation, including three full-time employees and two consultants. Included among these individuals are CIO Martin Erlandsson and CMO Richard Rosenbloom, who will thereby leave the management team of Carbiotix. At the same time, and as previously communicated, Carbiotix will be expanding its process engineering team to meet an increased demand for its NutraCycle service.Erik Deaner, CEO of Carbiotix,

SAS INAGURATES NEW ROUTE TO ATLANTA FROM COPENHAGEN

To meet the growing demand for travel to and from Scandinavia and the United States, SAS is expanding its North American network by adding a ninth destination. Starting on June 17th, SAS will offer daily nonstop flights from Copenhagen to Atlanta, providing customers with a new direct route to the U.S.Atlanta is a city worth visiting, offering something for everyone with its rich cultural experiences, historic landmarks, diverse culinary scene, and thriving sports scene. Handling nearly 104 million passengers in 2023, Hartsfield-Jackson Atlanta International Airport is the world's busiest

Frost & Sullivan Recognizes Critical Manufacturing as a Leading Vendor with the Highest Growth Potential on the Frost Radar™ for MES

June 17, 2024, PORTO, Portugal - Critical Manufacturing, a leading provider of Manufacturing Execution Systems (MES), has received high honors in Frost & Sullivan’s MES Radar™ report. Critical Manufacturing’s 50% year-over-year growth rate earned them top ranking for growth potential, and they were also among the top three for innovation and industry disruption.The report describes: “Critical Manufacturing is one of the most well-balanced companies in the MES sector, with a state-of-the-art technology stack, a wide range of targeted industry verticals, and a strong SI network that supports

Notification of major holding in Kindred Group plc

Kindred Group plc (Kindred) hereby announces that it, on 13 June 2024, has received a notification of major holding from JPMorgan Chase & Co, a company with its registered office in Wilmington, Delaware, USA. The notification refers to an increase in the number of shares and voting rights in Kindred held by JPMorgan Chase & Co.According to the notification, JPMorgan Chase & Co held 5.20% of the shares and voting rights in Kindred as of 11 June 2024. The relevant chain of controlled undertakings can be found in the notification, of which a copy can be found on Kindred’s website: https://

Södra to invest in bark-based tanning agent production

Södra is investing in a production line at Värö which will create a vegetable tanning agent from bark. This new tannin can be used to process leather in a more environmentally friendly way. Scheduled to be commissioned in 2026, the plant will have the capacity to produce tannins for millions of square metres of leather.Södra's Board of Directors has approved the project which will be an integral part of the Värö mill and is expected to be able to produce tanning material equivalent to millions of square metres of leather. "This investment decision fits well with our overall ambition to

There are no items matching the current filter
There are no more items matching the current filter
Back to top